Anbio Biotechnology Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| GEODE CAPITAL MANAGEMENT, LLC | 05/15/2026 | 25.76 K | $661.85 K | 0.00% | 0.06% |
| BNP PARIBAS ARBITRAGE, SNC | 05/12/2026 | 10.40 K | $267.18 K | 940.00% | 0.02% |
| MORGAN STANLEY | 05/15/2026 | 7.34 K | $188.51 K | 26,107.14% | 0.02% |
| UBS GROUP AG | 05/05/2026 | 6.34 K | $162.85 K | 122.50% | 0.01% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 266 | $6.83 K | 100.00% | 0.00% |
| WELLS FARGO & COMPANY/MN | 05/11/2026 | 100 | $2.57 K | 0.00% | 0.00% |
| BARE FINANCIAL SERVICES, INC | 05/14/2026 | 15 | $385 | 100.00% | 0.00% |
| RONALD BLUE TRUST, INC. | 04/20/2026 | 5 | $128 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Anbio Biotechnology institutional Ownership - FAQ's
During the previous two years, 8 institutional investors and hedge funds held shares of Anbio Biotechnology. The most heavily invested institutionals were:
GEODE CAPITAL MANAGEMENT, LLC: 25,763
BNP PARIBAS ARBITRAGE, SNC: 10,400
MORGAN STANLEY: 7,338
UBS Group AG: 6,339
EverSource Wealth Advisors, LLC: 266
WELLS FARGO & COMPANY/MN: 100
0.11% of Anbio Biotechnology stock is owned by institutional investors.
Institutional investors have bought a total of 50.23 K shares in the last 24 months. This purchase volume represents approximately $1.12 M in transactions.